Literature DB >> 25564483

Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.

Zsila Sadighi1, Noah D Sabin2, Randall Hayden2, Elizabeth Stewart2, Asha Pillai3.   

Abstract

Human herpesvirus 6 (HHV6) encephalitis and Wernicke encephalopathy are treatable yet frequently undiagnosed causes of encephalopathy in pediatric recipients of allogeneic and autologous hematopoietic cell transplantation. Here we review representative cases of both conditions to highlight specific and relevant neurologic features that prompted effective diagnosis and treatment. Two patients with confusion accompanied by seizures, memory changes, or specific visual hallucinations and HHV6 detectable by polymerase chain reaction (PCR) in cerebrospinal fluid had improvement in viral load with ganciclovir or foscarnet treatment. Two patients had confusion, ataxia, or ocular changes and low serum thiamine levels, which resolved with parenteral thiamine. In all cases, definitive diagnosis and treatment were facilitated by a high index of suspicion and search for specific pathognomonic neurologic deficits accompanying the confusional state. It is critical to clinically differentiate these 2 conditions from other common neurologic syndromes occurring after transplant, allowing potentially improved patient outcomes by prompt diagnosis and effective treatment.
© The Author(s) 2015.

Entities:  

Keywords:  Wernicke encephalopathy; central nervous system; hematopoietic cell transplant; human herpesvirus 6 encephalitis; thiamine

Mesh:

Year:  2015        PMID: 25564483      PMCID: PMC4692275          DOI: 10.1177/0883073814560628

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  48 in total

1.  Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.

Authors:  W Bethge; R Beck; G Jahn; P Mundinger; L Kanz; H Einsele
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

Review 2.  Human herpesvirus-6 and -7 in transplantation.

Authors:  D H Dockrell; C V Paya
Journal:  Rev Med Virol       Date:  2001 Jan-Feb       Impact factor: 6.989

3.  HLA-mismatched CD34-selected stem cell transplant complicated by HHV-6 reactivation in the central nervous system.

Authors:  Y Kawano; T Miyazaki; T Watanabe; A Suzue; S Kan-nuki; T Kagechi; T Onishi; M Kaneko; S Kanamaru; Y Wakata; R Nakagawa; K Suenaga; H Suzuya; T Abe; S Nagahiro; Y Kuroda; Y Takaue
Journal:  Bone Marrow Transplant       Date:  2000-04       Impact factor: 5.483

4.  Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients.

Authors:  Agnès Gautheret-Dejean; Chaysavanh Manichanh; Florence Thien-Ah-Koon; Anne-Marie Fillet; Nicole Mangeney; Michel Vidaud; Nathalie Dhedin; Jean-Paul Vernant; Henri Agut
Journal:  J Virol Methods       Date:  2002-02       Impact factor: 2.014

5.  Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases.

Authors:  L F Bleggi-Torres; B C de Medeiros; B Werner; J Z Neto; G Loddo; R Pasquini; C R de Medeiros
Journal:  Bone Marrow Transplant       Date:  2000-02       Impact factor: 5.483

6.  Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus.

Authors:  N Singh; D L Paterson
Journal:  Transplantation       Date:  2000-06-27       Impact factor: 4.939

Review 7.  Human herpesvirus-6 and -7 infections in transplantation.

Authors:  T Yoshikawa
Journal:  Pediatr Transplant       Date:  2003-02

8.  Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.

Authors:  Tetsushi Yoshikawa; Yoshizo Asano; Masaru Ihira; Kyoko Suzuki; Masahiro Ohashi; Sadao Suga; Kazuko Kudo; Keizo Horibe; Seiji Kojima; Koji Kato; Takaharu Matsuyama; Yukihiro Nishiyama
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

9.  Human herpesvirus 6 limbic encephalitis after stem cell transplantation.

Authors:  M S Wainwright; P L Martin; R P Morse; M Lacaze; J M Provenzale; R E Coleman; M A Morgan; C Hulette; J Kurtzberg; C Bushnell; L Epstein; D V Lewis
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

10.  Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.

Authors:  S Tokimasa; J Hara; Y Osugi; H Ohta; Y Matsuda; H Fujisaki; A Sawada; J Y Kim; J Sashihara; K Amou; H Miyagawa; K Tanaka-Taya; K Yamanishi; S Okada
Journal:  Bone Marrow Transplant       Date:  2002-04       Impact factor: 5.483

View more
  4 in total

Review 1.  Neurologic Complications of Transplantation.

Authors:  Rajat Dhar
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

Review 2.  Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.

Authors:  Andrés Server; Nuria Bargalló; Yngvar Fløisand; Jon Sponheim; Francesc Graus; John K Hald
Journal:  Neuroradiology       Date:  2017-03-02       Impact factor: 2.804

3.  Wernicke encephalopathy in a patient with liver failure: Clinical case report.

Authors:  Pan Zhao; Yanling Zhao; Zhenman Wei; Jing Chen; Lilong Yan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 4.  Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Authors:  Joseph Ongrádi; Dharam V Ablashi; Tetsushi Yoshikawa; Balázs Stercz; Masao Ogata
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.